Fusen Pharmaceutical Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 36.59 | -100% | 41.67 | -100% |
| P/S |
|
1.69 | 7.13 | -76.35% |
|
|
| P/BV |
|
1.87 | 3.66 | -48.94% |
|
|
| P/FCF |
|
-5.99 | 52.22 | -111.48% |
|
|
| Ev/Ebitda |
|
70.26 | 2.91 | 2316.34% |
|
|
| Ev/S |
|
2.18 | 19.3 | -88.7% |
|
|
| Ev/FCF |
|
-7.62 | 60.19 | -112.66% |
|
|
| E/P |
|
-0.0374 | 0.0326 | -214.65% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
2.68 | -9.58 | -127.96% | 10.61 | -74.78% |
| ROE |
|
-6.88 | 4.42 | -255.68% |
|
|
| ROA |
|
-3.01 | 2.95 | -201.91% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-6.41 | -11.15 | -42.5% |
|
|
| ROCE |
|
0 | 0.2615 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
13.95 | 0.7714 | 1708.75% | 10.04 | +38.96% |
| Nеt Debt/Ebitda |
|
18.46 | 0.0386 | 47697.22% |
|
|
| Debt/Ratio |
|
0.1729 | 0.1236 | 39.9% |
|
|
| Debt/Equity |
|
0.3495 | 0.7332 | -52.33% |
|
|
| Debt/Net Income |
|
-5.83 | 1.65 | -453.55% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0.4566 | -100% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0.6667 | 0.5838 | 14.19% |
|
|
| Average dividend growth |
|
-9.33 | 3.2 | -391.24% |
|
|
| Average percentage for 5 years |
|
0.4566 | 4.95 | -90.78% |
|
|
| Average percentage for payments |
|
41.17 | 24.82 | 65.88% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
48.58 | 1.85 | 2525.95% | ||
| Growth impulse Ebitda in 5 years |
|
-90.28 | -43.89 | 105.7% | ||
| Growth impulse Net Income in 5 years |
|
-172.61 | 58.07 | -397.24% | ||
| Growth impulse FCF in 5 years |
|
-3.71 | -65.24 | -94.31% | ||
| Growth impulse EPS in 5 years |
|
-833.8 | -198.43 | 320.2% |
IP Score
3.02/10
